Back to Market Feed

Product Information

TLANDO 112.5 MG CAPSULE is a brand product labeled by Antares Pharma, Inc., priced at $6.8232 per EA under NDC 54436011220. Its NADAC has been published 83 times since Apr 17, 2024.

FDA first approved this application on Mar 28, 2022.

TLANDO 112.5 MG CAPSULE

testosterone undecanoate
$6.8232per EA
Discontinued
DEA Schedule CIII

Strength

112.5 mg/1

NDC

54436011220

Classification

Brand

Dosage Form

CAPSULE, LIQUID FILLED

Route

ORAL

Effective Date

12/23/2024

Active Ingredients

TESTOSTERONE UNDECANOATE

Approval Type

New Drug (NDA)

FDA Application

NDA208088

FDA Approved

3/28/2022

On Market Since

4/15/2022

Pharmacological Classes

Androgen Receptor Agonists
Androgen
Androstanes

Price Statistics

The NADAC for TLANDO 112.5 MG CAPSULE has been published 83 times since Apr 17, 2024, and over the history we have for it it has risen 15.1%. The table below summarizes its recorded NADAC range and movement.

Current price$6.8232 per EA
All-time high$6.8232 (Nov 12, 2025)
All-time low$5.9299 (Apr 17, 2024)
52-week high$6.8232
52-week low$6.8232
Median price$6.8232
Average price$6.4263
Largest weekly change+15.0% (Jan 1, 2025)
Weeks tracked83
Tracking sinceApr 17, 2024

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

0.0%

3Y

N/A

5Y

N/A

All

+15.1%

Last surveyed Nov 12, 2025 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

TLANDO 112.5 MG CAPSULE
Brand
74676011202•Verity Pharmaceuticals Inc.
$7.1811
+5% more

Related Drugs

Same classification

TESTIM 1% (50 MG) GEL
Brand
66887000105•Endo USA Inc.
$3.7842
per GM
VOGELXO 50 MG/5 GRAM GEL
Brand
00245087105•Upsher-Smith Laboratories LLC
$3.7863
per GM
NATESTO NASAL 5.5 MG/0.122 GM
Brand
42667551101•Acerus Pharmaceuticals Corporation
$41.2770
per GM
XYOSTED 50 MG/0.5 ML AUTO-INJ
Brand
54436025004•Antares Pharma, Inc.
$316.0971
per ML
XYOSTED 75 MG/0.5 ML AUTO-INJ
Brand
54436027504•Antares Pharma, Inc.
$316.4489
per ML
XYOSTED 100 MG/0.5 ML AUTO-INJ
Brand
54436020004•Antares Pharma, Inc.
$316.6497
per ML

Frequently asked questions

What is the NADAC price of TLANDO 112.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TLANDO 112.5 MG CAPSULE, manufactured by Antares Pharma, Inc., is $6.8232 per EA (NDC 54436011220), effective Nov 12, 2025.

How has the price of TLANDO 112.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TLANDO 112.5 MG CAPSULE has risen 15.1%. It has been tracked across 83 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for TLANDO 112.5 MG CAPSULE?

Since Apr 17, 2024, the NADAC for TLANDO 112.5 MG CAPSULE has ranged from a low of $5.9299 (Apr 17, 2024) to a high of $6.8232 (Nov 12, 2025), with a median of $6.8232 per EA.

Are there cheaper alternatives to TLANDO 112.5 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TLANDO 112.5 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TLANDO 112.5 MG CAPSULE?

TLANDO 112.5 MG CAPSULE (NDC 54436011220) is labeled by Antares Pharma, Inc., and CMS classifies it as a brand product.